Related Experiment Videos
Factors influencing the development of hypertension after heart transplantation
E Ozdogan1, N Banner, M Fitzgerald
1Harefield Hospital, Middlesex, U.K.
Insights
Hypertension is common after heart transplantation, affecting 77% by 4 years. Risk factors include specific immunosuppressants, male sex, older age, and family history of cardiovascular disease.
Area of Science:
- Cardiology
- Transplant Surgery
- Nephrology
Background:
- Hypertension is a significant complication following heart transplantation.
- Understanding risk factors is crucial for patient management and improving long-term outcomes.
Purpose of the Study:
- To identify factors influencing the development of hypertension in heart transplant recipients.
- To analyze the impact of immunosuppressive regimens, patient demographics, and donor characteristics on post-transplant hypertension.
Main Methods:
- Retrospective analysis of 488 consecutive heart transplant recipients.
- Assessment of cumulative incidence of hypertension (BP > 150/95 mm Hg) over 4 years.
- Comparison of hypertension incidence based on immunosuppressive drugs (cyclosporine, azathioprine, prednisone), patient age, sex, and medical history.
Main Results:
- Cumulative hypertension probability reached 77% by 4 years post-transplant.
- Higher incidence observed with cyclosporine/azathioprine compared to prednisone/azathioprine.
- Male recipients, those older than 20, and those with a family history of cardiovascular disease had increased risk.
- Cyclosporine dosage, intermittent steroid use, kidney function, and donor factors did not significantly impact hypertension incidence.
Conclusions:
- Hypertension is a highly prevalent long-term complication after heart transplantation.
- Specific immunosuppressive regimens and patient-related factors are key predictors of post-transplant hypertension.
- Further research should focus on preventative strategies and tailored management for at-risk populations.
Abstract:
In this study we investigated the factors influencing the development of hypertension in 488 consecutive heart transplant recipients. The cumulative probability of hypertension (blood pressure persistently above 150/95 mm Hg) developing was 52% at 1 year, 67% at 2 years, 73% at 3 years, and 77% at 4 years after transplantation. The incidence was higher in patients receiving cyclosporine and azathioprine compared with those receiving prednisone and azathioprine immunosuppression. The dose of cyclosporine used did not appear to influence the development of hypertension. Intermittent steroid exposure did not increase the incidence in the cyclosporine group. Male transplant recipients and those older than 20 years appeared more prone to the development of hypertension. A family history of cardiovascular disease also increased the incidence. Preoperative and postoperative kidney dysfunction and transplantation because of ischemic heart disease did not appear to affect the incidence of hypertension. Donor characteristics, including the use of hearts from donors who weighed more than the recipients and from patients dying of spontaneous intracranial hemorrhage, did not appear to increase the incidence of hypertension after heart transplantation.